We are live on ! Find out more
HNB

Huntington National Bank Portfolio holdings

AUM $20.6B
1-Year Est. Return 34.61%
This Fund
S&P 500
This Quarter Est. Return
+11.92%
1 Year Est. Return
+34.61%
3 Year Est. Return
+104.62%
5 Year Est. Return
+130.19%
10 Year Est. Return
+421.74%
AUM
$12.4B
AUM Growth
+$1.43B
Cap. Flow
-$18M
Cap. Flow %
-0.14%
Top 10 Hldgs %
25.25%
Holding
4,194
New
180
Increased
916
Reduced
639
Closed
79

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$39.1M
2
SYK icon
Stryker
SYK
+$30.4M
3
PANW icon
Palo Alto Networks
PANW
+$30.1M
4
AVGO icon
Broadcom
AVGO
+$24.3M
5
LOW icon
Lowe's Companies
LOW
+$20.2M

Sector Composition

Rank Sector Weight
1 Technology 20.27%
2 Financials 9.94%
3 Healthcare 9.18%
4 Consumer Discretionary 7.17%
5 Industrials 6.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBH icon
1001
Prestige Consumer Healthcare
PBH
$2.42B
$68.6K ﹤0.01%
+945
New +$63.2K
XAR icon
1002
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.68B
0
VALE icon
1003
Vale
VALE
$58B
$68.2K ﹤0.01%
5,594
-164
-3% -$2.21K
WABC icon
1004
Westamerica Bancorp
WABC
$1.39B
$68.1K ﹤0.01%
1,394
+219
+19% +$10.6K
FNF icon
1005
Fidelity National Financial
FNF
$13.3B
$67.8K ﹤0.01%
1,277
-2,304
-64% -$116K
CRL icon
1006
Charles River Laboratories
CRL
$13.3B
$67.7K ﹤0.01%
250
+32
+15% +$7.64K
SF
1007
Stifel
SF
$13B
$67.7K ﹤0.01%
1,299
+238
+22% +$11.7K
VPL icon
1008
Vanguard FTSE Pacific ETF
VPL
$8.65B
0
HR icon
1009
Healthcare Realty
HR
$6.65B
$67.7K ﹤0.01%
4,782
-77
-2% -$1.16K
BUD icon
1010
AB InBev
BUD
$156B
$67.5K ﹤0.01%
1,111
-206
-16% -$12.9K
FLS icon
1011
Flowserve
FLS
$10.4B
$67.2K ﹤0.01%
1,472
+230
+19% +$9.69K
SUB icon
1012
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
0
HALO icon
1013
Halozyme
HALO
$11.2B
$67.1K ﹤0.01%
1,649
+31
+2% +$1.16K
CDC icon
1014
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$754M
0
CFG icon
1015
Citizens Financial Group
CFG
$31.5B
$66.9K ﹤0.01%
1,844
-146
-7% -$4.79K
VE
1016
DELISTED
VEOLIA ENVIRONNEMENT
VE
$66.9K ﹤0.01%
4,123
+673
+20% +$10.9K
CPB icon
1017
Campbell Soup
CPB
$6.93B
$66.9K ﹤0.01%
1,504
-1,724
-53% -$74.6K
MHK icon
1018
Mohawk Industries
MHK
$9.43B
$66.5K ﹤0.01%
508
+6
+1% +$674
EPR icon
1019
EPR Properties
EPR
$4.74B
$66.3K ﹤0.01%
1,562
+140
+10% +$6.1K
TOL icon
1020
Toll Brothers
TOL
$13.8B
$66.2K ﹤0.01%
512
+86
+20% +$9.36K
CFO icon
1021
VictoryShares US 500 Enhanced Volatility Wtd ETF
CFO
$430M
0
AXTA icon
1022
Axalta
AXTA
$7.99B
$66K ﹤0.01%
1,920
+186
+11% +$6.08K
UAL icon
1023
United Airlines
UAL
$40.5B
$65.9K ﹤0.01%
1,376
-135
-9% -$5.79K
AES icon
1024
AES
AES
$10.5B
$65.7K ﹤0.01%
3,664
+1,000
+38% +$16.7K
OLN icon
1025
Olin
OLN
$2.17B
$65.5K ﹤0.01%
1,114

Similar funds

Huntington National Bank's Q1 2024 Portfolio in Review

As of Q1 2024, Huntington National Bank held 4,194 positions worth $12.4B, up 13% from $11B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Huntington National Bank's Q1 2024 filing shows 180 new, 916 increased, 639 reduced and 79 closed positions. Its largest new stake was Rentokil: 3,572 shares worth $108K. The largest sale was UnitedHealth, an estimated $33.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Huntington National Bank's largest Q1 2024 buy was Rentokil: 3,572 shares worth $108K.
  • Huntington National Bank added most to Applied Materials in Q1 2024, an estimated $39.1M increase.
  • Huntington National Bank's biggest Q1 2024 reduction was UnitedHealth, cutting an estimated $33.5M.
  • Huntington National Bank fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $12.2M.
  • Huntington National Bank's ten largest holdings make up 25% of its $12.4B portfolio in Q1 2024.
  • Huntington National Bank opened 180 new positions and closed 79 in Q1 2024.
  • Huntington National Bank's portfolio value rose 13% quarter-over-quarter to $12.4B.

Based on Huntington National Bank's 13F filing for Q1 2024, filed 3 May 2024.